Skip to content
← Back to this collection

PUBLICATIONS · 23150707

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2012 Dec 10
First author
Gunderson LL

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Gunderson LL
      type
      Author
    2. name
      Winter KA
      type
      Author
    3. name
      Ajani JA
      type
      Author
    4. name
      Pedersen JE
      type
      Author
    5. name
      Moughan J
      type
      Author
    6. name
      Benson AB 3rd
      type
      Author
    7. name
      Thomas CR Jr
      type
      Author
    8. name
      Mayer RJ
      type
      Author
    9. name
      Haddock MG
      type
      Author
    10. name
      Rich TA
      type
      Author
    11. name
      Willett CG
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Gunderson LL
      type
      Author
    2. name
      Winter KA
      type
      Author
    3. name
      Ajani JA
      type
      Author
    4. name
      Pedersen JE
      type
      Author
    5. name
      Moughan J
      type
      Author
    6. name
      Benson AB 3rd
      type
      Author
    7. name
      Thomas CR Jr
      type
      Author
    8. name
      Mayer RJ
      type
      Author
    9. name
      Haddock MG
      type
      Author
    10. name
      Rich TA
      type
      Author
    11. name
      Willett CG
      type
      Author
    bibliography ids
    1. nci-bib-59d3193bf8fa86c963f5a3ec
    book metadata
    content sha256
    1222436dd506ff18392a047f7ae106a6c028caa36d65071463b093bc786ffdd9
    document type
    citation
    dois
    1. 10.1200/JCO.2012.43.8085
    electronic publication date
    display
    2012 Nov 13
    precision
    day
    year
    2012
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:23150707
    immutable id
    pubmed:23150707@1222436dd506ff18392a047f7ae106a6c028caa36d65071463b093bc786ffdd9
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    35
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    4344-51
    volume
    30
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      23150707
      provenance
      batch id
      99e85dbb34a1a3011c9a
      provider
      NCBI PubMed ESummary
      record sha256
      6ca796894175b058e0af65fb5c7b46fbe7711e9b1c44eb8605c79b27bb190b3a
      response sha256
      1f4a46dcee9da36f8f58fe356dce3f44a1b3004f404e9fb0184f4e08aed4acf2
      retrieved at
      2026-09-09T23:46:52.860383+00:00
      publication date
      display
      2012 Dec 10
      precision
      day
      year
      2012
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/23150707/
      title
      Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

      Preserved source evidence · Not medical advice